Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells

Virology

Volumn 381, Issue 2, 2008, Pages 203-214

  Chevaliez, Stéphane ^a   Balanant, Jean ^a   Maillard, Patrick ^a   Lone, Yu Chun ^a   Lemonnier, Francois A ^a   Delpeyroux, Francis ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Echovirus 11; Enterovirus; Human leukocyte antigen class I; Picornavirus; Receptors; Viral entry

Indexed keywords

BETA 2 MICROGLOBULIN; DECAY ACCELERATING FACTOR; HLA A2 ANTIGEN; HLA ANTIBODY; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ECHO VIRUS; ENTEROVIRUS INFECTION; HUMAN; HUMAN CELL; LEUKOCYTE; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RHABDOMYOSARCOMA; SARCOMA CELL; VIRUS CELL INTERACTION; VIRUS PARTICLE; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD55; BETA 2-MICROGLOBULIN; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; ECHOVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LEUKOCYTES; PROTEIN BINDING; RHABDOMYOSARCOMA; VIRUS REPLICATION;

ECHOVIRUS; ENTEROVIRUS; HUMAN ECHOVIRUS 11; PICORNAVIRIDAE;

EID: 54549114179     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.08.006     Document Type: Article

References (72)

1. Abastado J.P., Lone Y.C., Casrouge A., Boulot G., and Kourilsky P. Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness. J. Exp. Med. 182 2 (1995) 439-447
2. Anderson H.A., Chen Y., and Norkin L.C. MHC class I molecules are enriched in caveolae but do not enter with simian virus 40. J. Gen. Virol. 79 6 (1998) 1469-1477
3. Bergelson J.M., Shepley M.P., Chan B.M., Hemler M.E., and Finberg R.W. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255 5052 (1992) 1718-1720
4. Bergelson J.M., St John N., Kawaguchi S., Chan M., Stubdal H., Modlin J., and Finberg R.W. Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J. Virol. 67 11 (1993) 6847-6852
5. Bergelson J.M., Chan M., Solomon K.R., St John N.F., Lin H., and Finberg R.W. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. U. S. A. 91 13 (1994) 6245-6248
6. Berinstein A., Roivainen M., Hovi T., Mason P.W., and Baxt B. Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69 4 (1995) 2664-2666
7. Blondel B., Akacem O., Crainic R., Couillin P., and Horodniceanu F. Detection by monoclonal antibodies of an antigenic determinant critical for poliovirus neutralization present on VP1 and on heat inactivated virions. Virology 126 (1983) 707-710
8. Caro V., Guillot S., Delpeyroux F., and Crainic R. Molecular strategy for 'serotyping' of human enteroviruses. J. Gen. Virol. 82 1 (2001) 79-91
9. Casasnovas J.M., and Springer T.A. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J. Virol. 68 9 (1994) 5882-5889
10. Chevaliez S., Szendroi A., Caro V., Balanant J., Guillot S., Berencsi G., and Delpeyroux F. Molecular comparison of echovirus 11 strains circulating in Europe during an epidemic of multisystem hemorrhagic disease of infants indicates that evolution generally occurs by recombination. Virology 325 1 (2004) 56-70
11. Clarkson N.A., Kaufman R., Lublin D.M., Ward T., Pipkin P.A., Minor P.D., Evans D.J., and Almond J.W. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J. Virol. 69 9 (1995) 5497-5501
12. Coyne K.E., Hall S.E., Thompson S., Arce M.A., Kinoshita T., Fujita T., Anstee D.J., Rosse W., and Lublin D.M. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149 9 (1992) 2906-2913
13. Deckert M., Kubar J., and Bernard A. CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. J. Immunol. 148 3 (1992) 672-677
14. DeTulleo L., and Kirchhausen T. The clathrin endocytic pathway in viral infection. EMBO. J. 17 16 (1998) 4585-4593
15. El-Sageyer M.M., Szendroi A., Hutter E., Uj M., Szucs G., Mezey I., Toth I., Katai A., Kapiller Z., Pall G., Petras G., Szalay E., Mihaly I., Gourova S., and Berencsi G. Characterisation of an echovirus type 11′ (prime) epidemic strain causing haemorrhagic syndrome in newborn babies in Hungary. Acta. Virol. 42 3 (1998) 157-166
16. Firat H., Tourdot S., Ureta-Vidal A., Scardino A., Suhrbier A., Buseyne F., Riviere Y., Danos O., Michel M.L., Kosmatopoulos K., and Lemonnier F.A. Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A*0201 transgenic, H-2 class I KO mice. Eur. J. Immunol. 31 10 (2001) 3064-3074
17. Gomez Yafal A., Kaplan G., Racaniello V.R., and Hogle J.M. Characterization of poliovirus conformational alteration mediated by soluble cell receptors. Virology 197 1 (1993) 501-505
18. Goodfellow I.G., Powell R.M., Ward T., Spiller O.B., Almond J.W., and Evans D.J. Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59. J. Gen. Virol. 81 5 (2000) 1393-1401
19. Goodfellow I.G., Sioofy A.B., Powell R.M., and Evans D.J. Echoviruses bind heparan sulfate at the cell surface. J. Virol. 75 10 (2001) 4918-4921
20. Greve J.M., Davis G., Meyer A.M., Forte C.P., Yost S.C., Marlor C.W., Kamarck M.E., and McClelland A. The major human rhinovirus receptor is ICAM-1. Cell 56 5 (1989) 839-847
21. Gromeier M., and Wetz K. Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment. J. Virol. 64 8 (1990) 3590-3597
22. Haddad A., Nokhbeh M.R., Alexander D.A., Dawe S.J., Grise C., Gulzar N., and Dimock K. Binding to decay-accelerating factor is not required for infection of human leukocyte cell lines by enterovirus 70. J. Virol. 78 6 (2004) 2674-2681
23. Hong S.S., Karayan L., Tournier J., Curiel D.T., and Boulanger P.A. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J. 16 9 (1997) 2294-2306
24. Huttunen P., Santti J., Pulli T., and Hyypia T. The major echovirus group is genetically coherent and related to coxsackie B viruses. J. Gen. Virol. 77 (1996) 715-725
25. Karnauchow T.M., Tolson D.L., Harrison B.A., Altman E., Lublin D.M., and Dimock K. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 70 8 (1996) 5143-5152
26. Kim M.S., and Racaniello V.R. Enterovirus 70 receptor utilization is controlled by capsid residues that also regulate host range and cytopathogenicity. J. Virol. 81 16 (2007) 8648-8655
27. Klein E., Klein G., Nadkarni J.S., Nadkarni J.J., Wigzell H., and Clifford P. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer. Res. 28 7 (1968) 1300-1310
28. Kopecka H., Brown B., and Pallansch M. Genotypic variation in coxsackievirus B5 isolates from three different outbreaks in the United States. Virus Res. 38 2-3 (1995) 125-136
29. Laffin J., and Lehman J.M. Detection of intracellular virus and viral products. Methods Cell Biol. 41 (1994) 543-557
30. Layet C., Le Bouteiller P.P., N'Guyen C., Mercier P., Rosa F., Fellous M., Caillol D.H., Jordan B.R., and Lemonnier F.A. Transformation of LMTK-cells with purified HLA class I gene. VI. Serological characterization of HLA-B7 and AW24 molecules. Hum. Immunol. 11 1 (1984) 31-45
31. Lea S.M., Powell R.M., McKee T., Evans D.J., Brown D., Stuart D.I., and van der Merwe P.A. Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55. J. Biol. Chem. 273 46 (1998) 30443-30447
32. Lone Y.C., Motta I., Mottez E., Guilloux Y., Lim A., Demay F., Levraud J.P., Kourilsky P., and Abastado J.P. In vitro induction of specific cytotoxic T lymphocytes using recombinant single-chain MHC class I/peptide complexes. J. Immunother. 21 4 (1998) 283-294
33. Lublin D.M., and Atkinson J.P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7 (1989) 35-58
34. Lukashev A.N., Lashkevich V.A., Koroleva G.A., Ilonen J., Karganova G.G., Reznik V.I., and Hinkkanen A.E. Molecular epidemiology of enteroviruses causing uveitis and multisystem hemorrhagic disease of infants. Virology 307 1 (2003) 45-53
35. Malissen B., Rebai N., Liabeuf A., and Mawas C. Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur. J. Immunol. 12 9 (1982) 739-747
36. Marjomaki V., Pietiainen V., Matilainen H., Upla P., Ivaska J., Nissinen L., Reunanen H., Huttunen P., Hyypia T., and Heino J. Internalization of echovirus 1 in caveolae. J. Virol. 76 4 (2002) 1856-1865
37. McSharry J.J., Costantino R., Robbiano E., Echols R., Stevens R., and Lehman J.M. Detection and quantitation of human immunodeficiency virus-infected peripheral blood mononuclear cells by flow cytometry. J. Clin. Microbiol. 28 4 (1990) 724-733
38. Melnick J.L. Enteroviruses : polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Fields D.M.K.B.N., Howley P.M., Channock R.M., Melnick J.L., Monath T.P., Roizman B., and Straus S.E. (Eds). Fields Virology. third edition (1996), Lippincott-Raven Publishers, Philadelphia 655-712
39. Mendelsohn C.L., Wimmer E., and Racaniello V.R. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56 5 (1989) 855-865
40. Motta I., Lone Y.C., and Kourilsky P. In vitro induction of naive cytotoxic T lymphocytes with complexes of peptide and recombinant MHC class I molecules coated onto beads: role of TCR/ligand density. Eur. J. Immunol. 28 11 (1998) 3685-3695
41. Mullins J.A., Khetsuriani N., Nix W.A., Oberste M.S., LaMonte A., Kilpatrick D.R., Dunn J., Langer J., McMinn P., Huang Q.S., Grimwood K., Huang C., and Pallansch M.A. Emergence of echovirus type 13 as a prominent enterovirus. Clin. Infect. Dis. 38 1 (2004) 70-77
42. Neff S., Sa-Carvalho D., Rieder E., Mason P.W., Blystone S.D., Brown E.J., and Baxt B. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J. Virol. 72 5 (1998) 3587-3594
43. Newcombe N.G., Andersson P., Johansson E.S., Au G.G., Lindberg A.M., Barry R.D., and Shafren D.R. Cellular receptor interactions of C-cluster human group A coxsackieviruses. J. Gen. Virol. 84 11 (2003) 3041-3050
44. Newcombe N.G., Johansson E.S., Au G., Lindberg A.M., Barry R.D., and Shafren D.R. Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection. J. Virol. 78 3 (2004) 1431-1439
45. Nilsson K., Evrin P.E., and Welsh K.I. Production of beta 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant. Rev. 21 (1974) 53-84
46. Oberste M.S., Nix W.A., Kilpatrick D.R., Flemister M.R., and Pallansch M.A. Molecular epidemiology and type-specific detection of echovirus 11 isolates from the Americas, Europe, Africa, Australia, southern Asia and the Middle East. Virus Res. 91 2 (2003) 241-248
47. Pallansch M., and Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe D., and Howley P. (Eds). Fields Virology Vol. 1 (2001), Lippincott Williams and Wilkins, Philadelphia 723-775
48. Parham P., Barnstable C.J., and Bodmer W.F. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J. Immunol. 123 1 (1979) 342-349
49. Pasch A., Kupper J.H., Wolde A., Kandolf R., and Selinka H.C. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J. Gen. Virol. 80 12 (1999) 3153-3158
50. Pascolo S., Bervas N., Ure J.M., Smith A.G., Lemonnier F.A., and Perarnau B. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2 m) HLA-A2.1 monochain transgenic H-2Db beta2 m double knockout mice. J. Exp. Med. 185 12 (1997) 2043-2051
51. Pettigrew D.M., Williams D.T., Kerrigan D., Evans D.J., Lea S.M., and Bhella D. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor. J. Biol. Chem. 281 8 (2006) 5169-5177
52. Powell R.M., Ward T., Evans D.J., and Almond J.W. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J. Virol. 71 12 (1997) 9306-9312
53. Powell R.M., Schmitt V., Ward T., Goodfellow I., Evans D.J., and Almond J.W. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J. Gen. Virol. 79 7 (1998) 1707-1713
54. Rebai N., and Malissen B. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens 22 2 (1983) 107-117
55. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., and Hyypia T. Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 203 2 (1994) 357-365
56. Roivainen M., Piirainen L., and Hovi T. Efficient RGD-independent entry process of coxsackievirus A9. Arch. Virol. 141 10 (1996) 1909-1919
57. Schmidtke M., Selinka H.C., Heim A., Jahn B., Tonew M., Kandolf R., Stelzner A., and Zell R. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Virology 275 1 (2000) 77-88
58. Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., and Barry R.D. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 69 6 (1995) 3873-3877
59. Shafren D.R., Dorahy D.J., Ingham R.A., Burns G.F., and Barry R.D. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J. Virol. 71 6 (1997) 4736-4743
60. Shafren D.R., Williams D.T., and Barry R.D. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J. Virol. 71 12 (1997) 9844-9848
61. Snyder J.T., Belyakov I.M., Dzutsev A., Lemonnier F., and Berzofsky J.A. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+T-cell peptide epitope of vaccinia and variola viruses. J. Virol. 78 13 (2004) 7052-7060
62. Stuart A.D., Eustace H.E., McKee T.A., and Brown T.D. A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. J. Virol. 76 18 (2002) 9307-9322
63. Stuart A.D., McKee T.A., Williams P.A., Harley C., Shen S., Stuart D.I., Brown T.D., and Lea S.M. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection. J. Virol. 76 15 (2002) 7694-7704
64. Triantafilou M., Triantafilou K., Wilson K.M., Takada Y., Fernandez N., and Stanway G. Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle. J. Gen. Virol. 80 10 (1999) 2591-2600
65. Triantafilou K., Fradelizi D., Wilson K., and Triantafilou M. GRP78, a coreceptor for coxsackievirus A9, interacts with major histocompatibility complex class I molecules which mediate virus internalization. J. Virol. 76 2 (2002) 633-643
66. Tsai B., Gilbert J.M., Stehle T., Lencer W., Benjamin T.L., and Rapoport T.A. Gangliosides are receptors for murine polyoma virus and SV40. EMBO J. 22 17 (2003) 4346-4355
67. Vuorinen T., Vainionpaa R., Heino J., and Hyypia T. Enterovirus receptors and virus replication in human leukocytes. J. Gen. Virol. 80 4 (1999) 921-927
68. Ward T., Pipkin P.A., Clarkson N.A., Stone D.M., Minor P.D., and Almond J.W. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 13 21 (1994) 5070-5074
69. Ward T., Powell R.M., Pipkin P.A., Evans D.J., Minor P.D., and Almond J.W. Role for beta2-microglobulin in echovirus infection of rhabdomyosarcoma cells. J. Virol. 72 7 (1998) 5360-5365
70. Williams C.H., Kajander T., Hyypia T., Jackson T., Sheppard D., and Stanway G. Integrin alpha v beta 6 is an RGD-dependent receptor for coxsackievirus A9. J. Virol. 78 13 (2004) 6967-6973
71. Zautner A.E., Korner U., Henke A., Badorff C., and Schmidtke M. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection. J. Virol. 77 18 (2003) 10071-10077
72. Zautner A.E., Jahn B., Hammerschmidt E., Wutzler P., and Schmidtke M. N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J. Virol. 80 13 (2006) 6629-6636